TG Therapeutics Inc logo

TG Therapeutics Inc

FRA:NKB2 (USA)   Ordinary Shares
€ 21.19 (+1.95%) Sep 16
41.48
P/B:
21.70
Market Cap:
€ 3.48B ($ 3.86B)
Enterprise V:
€ 3.38B ($ 3.76B)
Volume:
30.00
Avg Vol (2M):
2.78K
Trade In:

TG Therapeutics Inc Operating Data

TG Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

TG Therapeutics Inc (FRA:NKB2) Operating Data Charts